Evidence map›Paper›PMID 42352423›Full record

ArticleCancers2026

A Novel Swarm Intelligence-Driven Feature Selection for Interpretable Machine Learning in Multiparametric MRI-Based GBM Overall Survival Analysis.

Abdulkerim Duman, Xianfang Sun, James R Powell, Emiliano Spezi

Abstract read
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Abdulkerim DumanSchool of Engineering, Cardiff University, Cardiff CF24 3AA, UK.ORCID 0000-0003-2747-1294
Xianfang SunSchool of Computer Science and Informatics, Cardiff University, Cardiff CF24 4AG, UK.ORCID 0000-0002-6114-0766
James R PowellDepartment of Oncology, Velindre University NHS Trust, Cardiff CF14 2TL, UK.
Emiliano SpeziSchool of Engineering, Cardiff University, Cardiff CF24 3AA, UK.ORCID 0000-0002-1452-8813

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesIn this study, we develop and validate an interpretable machine learning (ML) model that integrates a hybrid swarm intelligence (SI)-based feature selection method with multiparametric magnetic resonance imaging (MRI)-derived RFs to estimate overall survival (OS) in glioblastoma multiforme (GBM) patients.

methodsA cohort of 276 GBM patients with open-access pre-treatment MRI data was used to perform comprehensive radiomic analysis. In the training (discovery) dataset, we employed five-fold cross-validation combined with bootstrapping to ensure robust methodological validation. Model evaluation covered the concordance index (C-index) with 95% confidence intervals (CIs). Additionally, survival stratification was performed using Kaplan-Meier curves and the log-rank test to separate patients into low- and high-risk groups for OS. The final survival model integrates patient age and ten independent RFs.

resultsThe model's performance in the holdout test dataset was evaluated by a C-index of 0.71 (95% CI: 0.63-0.80), exhibiting statistically significant risk stratification (

conclusionsThe research combined a traditional regularized Cox regression (Cox-LASSO) model with a new SI-based LASSO-PSO method, yielding significant stratification. To our knowledge, the present study offers one of the first studies to document the use of an interpretable ML model with an SI-based approach for successful risk stratification based on OS.

Indexed as

artificial intelligencebrain tumorGBMprecision oncologyquantitative imaging biomarkersradiomicssurvival analysis

Identifiers

PMID42352423
PMCPMC13296785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.